IPO registrations (S-1, F-1) · Registrants
Applied Molecular Transport Inc.
- SEC CIK
- 1801777 · filings on EDGAR ↗
- Former names
- Applied Molecular Transport LLC (2020–2020)
- Registration
- Form S-1, first filed 2020-05-18, last 2021-03-29; 2 initial registrations, 1 amendment
- Outcome
- Final prospectus filed 2020-06-05; declared effective 2020-06-04
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- C/O THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER, 1209 ORANGE ST, Wilmington, DE 19801
- EIN
- 81-4481426
- EDGAR entity type
- operating
- Insiders and CEO pay
- Applied Molecular Transport Inc. on the corporate pages
Offering terms
- Proposed price range
- $12.00–$14.00 per share (S-1/A filed 2020-06-01)
- Final price
- $14.00 per share, within the range (424B4 filed 2020-06-05, an initial public offering)
- Shares sold
- 11,000,000
- Gross proceeds
- $154,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol AMTI
- Lead underwriters
- BofA Securities; Jefferies; Leerink Partners
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: Applied Molecular Transport Inc. EXACT (CIK (EXACT))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-05-18 | S-1 | S-1 (registration) | Applied Molecular Transport Inc. | 0001193125-20-145011 ↗ |
| 2020-06-01 | S-1/A | S-1/A (amendment) | Applied Molecular Transport Inc. | 0001193125-20-156385 ↗ |
| 2020-06-04 | S-1MEF | S-1MEF (added securities) | Applied Molecular Transport Inc. | 0001193125-20-161043 ↗ |
| 2020-06-04 | EFFECT | EFFECT (declared effective) | Applied Molecular Transport Inc. | 9999999995-20-001337 ↗ |
| 2020-06-05 | 424B4 | 424B4 (final prospectus) | Applied Molecular Transport Inc. | 0001193125-20-162282 ↗ |
| 2021-03-29 | S-1 | S-1 (registration) | Applied Molecular Transport Inc. | 0001193125-21-098259 ↗ |
| 2021-03-31 | EFFECT | EFFECT (declared effective) | Applied Molecular Transport Inc. | 9999999995-21-001244 ↗ |
| 2021-04-01 | 424B4 | 424B4 (final prospectus) | Applied Molecular Transport Inc. | 0001193125-21-103958 ↗ |
| 2022-03-25 | EFFECT | EFFECT (declared effective) | Applied Molecular Transport Inc. | 9999999995-22-000728 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-06-01 | S-1/A | registration statement | $12.00–$14.00 | 10,000,000 | - | Nasdaq AMTI | 3 | primary document; range, shares headline, cover names 3 | document ↗ | |
| 2020-06-05 | 424B4 | final prospectus | $14.00 | 11,000,000 | $154,000,000 | Nasdaq AMTI | 3 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bhatt Elizabeth | Officer | Chief Bus. & Strategy Officer | 6 | 2020–2022 | |
| COOPER GRAHAM K | Director | 3 | 2020–2022 | ||
| Cross Shawn | Director,Officer; Officer | CEO & Chair of the Board; Chief Financial Officer; President & COO | 16 | 2020–2023 | |
| EPIQ Capital Group, LLC | Other | 5 | 2020–2023 | ||
| EPQ LLC, AMTB PS | Other; TenPercentOwner | 5 | 2020–2023 | ||
| EPQ LLC AMT PS | Other; TenPercentOwner | 5 | 2020–2023 | ||
| Founders Fund V Entrepreneurs Fund, LP | TenPercentOwner | 2 | 2020 | ||
| Founders Fund VI Entrepreneurs Fund, LP | TenPercentOwner | 2 | 2020 | ||
| Founders Fund VI, LP | TenPercentOwner | 2 | 2020 | ||
| Founders Fund VI Principals Fund, LP | TenPercentOwner | 2 | 2020 | ||
| Founders Fund V, LP | TenPercentOwner | 2 | 2020 | ||
| Founders Fund V Principals Fund, LP | TenPercentOwner | 2 | 2020 | ||
| Hants Brandon | Officer | CFO; VP, Finance & Bus. Ops. | 16 | 2020–2023 | |
| Kanwar Bittoo | Officer | Chief Medical Officer | 12 | 2020–2023 | |
| Kim Helen Susan | Director | 6 | 2020–2021 | ||
| Lamond David | Director | 6 | 2020–2022 | ||
| Mahmood Tahir Ph.D. | Director; Director,Officer | Chief Executive Officer | 13 | 2020–2023 | |
| Mrsny Randall Ph.D. | Director; Director,Officer | Chief Scientific Officer | 8 | 2020–2022 | |
| VanDevender Aaron | Director | 8 | 2020–2023 | ||
| EPQ LLC, AMTC PS | Other | 4 | 2020–2023 | ||
| Rich Douglas A. | Officer | Chief Technical Officer | 10 | 2021–2023 | |
| Schachner Holly Caren | Director | 5 | 2021–2023 | ||
| Smither John W | Director | 5 | 2022–2023 | ||
| Banard Charlene A. | Director | 5 | 2022–2023 | ||
| Boeding Chad | Other | 2 | 2022–2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | Applied Molecular Transport Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, DE first:
- Merus N.V. DE
- Prelude Therapeutics Inc DE
- NRX Pharmaceuticals, Inc. DE
- Lomond Therapeutics Holdings, Inc. DE
- NovaCardia Inc CA
- MyoKardia, Inc. CA
- Bioquest Corp CA
- Regen BioPharma Inc CA
- Catalent, Inc. NJ
- Korro Bio, Inc. MA
In other datasets, the same topic (Health) in DE:
- Nonprofit: 1212 CORPORATION (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health